Skip to main content
ISR-Stats-august-19-ISR-web-tnail

For companies considering life cycle extension strategies for their oral dose products, there are clear preferences as to which strategies they would pursue. While strategies like Abuse deterrent, Fixed dose combinations, Taste masking, and Use of nanotechnology in drug delivery were also mentioned, the four strategies below are the most commonly considered.

Originally published in Life Science Leader.

View Resource